My goal is to support Westporters at every stage of their health journey, physically, emotionally and financially. As insurance plans, pharmacies and healthcare systems begin adapting to the agreement, Westport residents can expect: Lower long-term treatment costs Expanded coverage options More accessible weight-loss and diabetes therapies Better support managing chronic conditions For individuals and families, these improvements can open the door to more sustainable health choices and improve quality of life
Glucagon-like peptide-1 (GLP-1) receptor agonists, FDA-approved medications for type 2 diabetes and weight management, have recently sparked interest for an unexpected effect: some patients report reduced desire to drink alcohol while taking these drugs
Vascular risk factors: a ticking time bomb to Alzheimer's disease
What sets us apart is our commitment to delivering results for injured consumers and ensuring they receive the rightful compensation they deserve
doi: 10.1007/s00592-011-0359-9
holds non-exercised options in Kallyope